SUNPOWER CORP Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing
SUNPOWER CORP reported Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing of -$32.00 thousand for the 3-month period ending 2017-04-02, per its 10-Q filed 2017-05-10.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTesting · last filed 2017-05-10
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2017-04-02 was -$32.00K.
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2017-01-01 was -$719.00K, a 213.05% decline year-over-year.
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2016-10-02 was $117.00K, a 82.43% decline year-over-year.
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2016-07-03 was -$1.21M.
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for fiscal 2017 was $1.07M, a 44.47% decline from fiscal 2016.
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for fiscal 2016 was $1.93M, a 173.44% increase from fiscal 2014.
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for fiscal 2014 was $704.00K, a 76.76% decline from fiscal 2013.
- SUNPOWER CORP derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for fiscal 2013 was $3.03M, a 63.46% increase from fiscal 2012.
| Period end | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 3 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 3 month as first filed | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 6 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 6 month as first filed | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 9 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 12 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-04-02 | -$32.00K 10-Q · filed 2017-05-10 | -$751.00K derived: sum of 2 quarters · filed 2017-05-10 | -$634.00K derived: sum of 3 quarters · filed 2017-05-10 | -$1.84M derived: sum of 4 quarters · filed 2017-05-10 | |||
| 2017-01-01 | -$719.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$602.00K derived: sum of 2 quarters · filed 2017-02-17 | -$1.81M derived: sum of 3 quarters · filed 2017-02-17 | $1.07M 10-K · filed 2017-02-17 | |||
| 2016-10-02 | $117.00K 10-Q · filed 2016-11-10 | -$1.09M derived: sum of 2 quarters · filed 2016-11-10 | $1.79M 10-Q · filed 2016-11-10 | -$918.00K derived: sum of 4 quarters · filed 2017-05-10 | |||
| 2016-07-03 | -$1.21M 10-Q · filed 2016-08-10 | $1.67M 10-Q · filed 2016-08-10 | -$1.03M derived: sum of 3 quarters · filed 2017-05-10 | -$369.00K derived: sum of 4 quarters · filed 2017-05-10 | |||
| 2016-04-03 | -$460.00K 10-Q · filed 2017-05-10 | $460.00K 10-Q · filed 2016-05-06 | $176.00K derived: sum of 2 quarters · filed 2017-05-10 | $842.00K derived: sum of 3 quarters · filed 2017-05-10 | -$1.13M derived: sum of 4 quarters · filed 2017-05-10 | ||
| 2016-01-03 | $636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $1.30M derived: sum of 2 quarters · filed 2017-02-17 | -$666.00K derived: sum of 3 quarters · filed 2017-02-17 | $1.93M 10-K · filed 2017-02-17 | |||
| 2015-09-27 | $666.00K 10-Q · filed 2016-11-10 | -$666.00K 10-Q · filed 2015-10-29 | -$1.30M derived: sum of 2 quarters · filed 2016-11-10 | $1.29M 10-Q · filed 2016-11-10 | -$4.62M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-06-28 | -$1.97M 10-Q · filed 2016-08-10 | -$5.22M 10-Q · filed 2016-08-10 | $5.22M 10-Q · filed 2015-07-29 | -$5.29M derived: sum of 3 quarters · filed 2017-02-17 | -$5.33M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-03-29 | -$3.25M 10-Q · filed 2016-05-06 | $3.25M 10-Q · filed 2015-04-30 | -$3.32M derived: sum of 2 quarters · filed 2017-02-17 | -$3.36M derived: sum of 3 quarters · filed 2017-02-17 | -$3.03M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2014-12-28 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$107.00K derived: sum of 2 quarters · filed 2017-02-17 | $224.00K derived: sum of 3 quarters · filed 2017-02-17 | $704.00K 10-K · filed 2017-02-17 | -$704.00K 10-K · filed 2015-02-24 | ||
| 2014-09-28 | -$42.00K 10-Q · filed 2015-10-29 | $289.00K derived: sum of 2 quarters · filed 2015-10-29 | $769.00K 10-Q · filed 2015-10-29 | $5.92M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-29 | $331.00K 10-Q/A · filed 2015-10-29 | $811.00K 10-Q/A · filed 2015-10-29 | $5.96M derived: sum of 3 quarters · filed 2016-02-19 | $4.34M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-30 | $480.00K 10-Q · filed 2015-04-30 | $5.63M derived: sum of 2 quarters · filed 2016-02-19 | $4.01M derived: sum of 3 quarters · filed 2016-02-19 | $4.30M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-29 | $5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $3.53M derived: sum of 2 quarters · filed 2016-02-19 | $3.82M derived: sum of 3 quarters · filed 2016-02-19 | $3.03M 10-K · filed 2016-02-19 | -$3.03M 10-K · filed 2014-02-18 | ||
| 2013-09-29 | -$1.62M 10-Q · filed 2014-10-29 | -$1.33M derived: sum of 2 quarters · filed 2014-10-29 | -$2.12M 10-Q · filed 2014-10-29 | ||||
| 2013-06-30 | $286.00K 10-Q · filed 2014-07-31 | -$503.00K 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | -$789.00K 10-Q · filed 2014-04-30 | ||||||
| 2012-12-30 | $1.85M 10-K · filed 2015-02-24 | -$1.85M 10-K · filed 2014-02-18 | |||||
| 2012-01-01 | -$18.23M 10-K · filed 2014-02-18 |